Achieve Life Sciences (NASDAQ: ACHV)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-10 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.810 | -0.800 | 0.0100 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Achieve Life Sciences (NASDAQ: ACHV) through any online brokerage.
Other companies in Achieve Life Sciences’s space includes: Connect Biopharma Hldgs (NASDAQ:CNTB), Evaxion Biotech (NASDAQ:EVAX), Aligos Therapeutics (NASDAQ:ALGS), OKYO Pharma (NASDAQ:OKYO) and Frequency Therapeutics (NASDAQ:FREQ).
The latest price target for Achieve Life Sciences (NASDAQ: ACHV) was reported by Alliance Global Partners on Monday, October 4, 2021. The analyst firm set a price target for 25.00 expecting ACHV to rise to within 12 months (a possible 409.16% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Achieve Life Sciences (NASDAQ: ACHV) is $4.91 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Achieve Life Sciences.
Achieve Life Sciences’s Q2 earnings are confirmed for Wednesday, August 10, 2022.
There is no upcoming split for Achieve Life Sciences.
Achieve Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.